A multicentre, randomised, double-blind, placebo-controlled trial with interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANA-JIS trial) - Quartier, P (Ann Rheum Dis, 2011)
et al.